Literature DB >> 17900882

Tissue effects after stereotactic body radiotherapy using cyberknife for patients with abdominal malignancies.

J S Cupp1, A C Koong, G A Fisher, J A Norton, K A Goodman.   

Abstract

AIMS: To report the tissue effects of treatment with single fraction stereotactic body radiotherapy (SBRT) using Cyberknife on malignant tumours of the abdomen and adjacent normal organs.
MATERIALS AND METHODS: The data from four autopsies with unresectable pancreatic carcinoma and one lymph node excision from a case of recurrent neuroblastoma were reviewed for radiation-related tissue effects within the primary cancer and the normal organs within the radiation field.
RESULTS: Cases of unresectable pancreatic carcinoma consistently showed radiation-induced changes in both the primary tumour and the adjacent, non-malignant colorectal tissue. An additional case of lymph nodes exposed to stereotactic radiation showed typical radiation-related changes, including lymphocyte depletion and capsular fibrosis.
CONCLUSIONS: A myriad of radiation-related tissue effects are seen after SBRT with Cyberknife. The changes parallel those reported after conventionally fractionated radiotherapy and suggest that the pathophysiological mechanisms of radiation-induced normal tissue damage are similar for biologically equivalent single and fractionated doses of radiotherapy.

Entities:  

Mesh:

Year:  2007        PMID: 17900882     DOI: 10.1016/j.clon.2007.08.009

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  5 in total

1.  Stereotactic body radiation therapy (SBRT) for adrenal metastases : a feasibility study of advanced techniques with modulated photons and protons.

Authors:  Marta Scorsetti; Pietro Mancosu; Piera Navarria; Angelo Tozzi; Simona Castiglioni; Elena Clerici; Giacomo Reggiori; Francesca Lobefalo; Antonella Fogliata; Luca Cozzi
Journal:  Strahlenther Onkol       Date:  2011-03-25       Impact factor: 3.621

2.  Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer.

Authors:  Jung Hyun Kwon; Si Hyun Bae; Ji Yoon Kim; Byung Ock Choi; Hong Seok Jang; Jeong Won Jang; Jong Young Choi; Seung Kew Yoon; Kyu Won Chung
Journal:  BMC Cancer       Date:  2010-09-03       Impact factor: 4.430

3.  Incidence and characteristics of death from peptic ulcer among cancer patients in the United States.

Authors:  Pengcheng Yang; Yongqiang Zheng; Lei Zhang; Xiaohua Hou
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.379

4.  Stereotactic body radiotherapy for metachronous multisite oligo-recurrence: a long-surviving case with sequential oligo-recurrence in four different organs treated using locally radical radiotherapy and a review of the literature.

Authors:  Hiroshi Onishi; Masatoki Ozaki; Kengo Kuriyama; Takafumi Komiyama; Kan Marino; Masayuki Araya; Ryo Saito; Shinichi Aoki; Yoshiyasu Maehata; Licht Tominaga; Mitsuhiko Oguri; Iori Watanabe; Kojiro Onohara; Meguru Watanabe; Naoki Sano; Tsutomu Araki
Journal:  Pulm Med       Date:  2012-10-23

Review 5.  Normal tissue toxicity after small field hypofractionated stereotactic body radiation.

Authors:  Michael T Milano; Louis S Constine; Paul Okunieff
Journal:  Radiat Oncol       Date:  2008-10-31       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.